潤都股份(002923.SZ)取得換髮《藥品生產許可證》
格隆匯 12 月 21日丨潤都股份(002923.SZ)公佈,公司原有《藥品生產許可證》將於2020年12月31日到期。近日,公司收到廣東省藥品監督管理局換髮的《藥品生產許可證》。新的《藥品生產許可證》基本信息如下:
企業名稱:珠海潤都製藥股份有限公司;社會信用代碼:91440400192520640G;註冊地址:珠海市金灣區三灶鎮機場北路6號;法定代表人:劉傑;企業負責人:劉傑;質量負責人:蘇軍;有效期至:2025年12月10日;生產地址和生產範圍:珠海市金灣區三灶鎮機場北路6號、原料藥,小容量注射劑,片劑,硬膠囊劑,幹混懸劑,製劑中間體(微丸)。許可證編號:粵20160246;分類碼:AhxDh。
此次《藥品生產許可證》換髮是基於原證即將到期,新證的取得確保了公司的正常生產;上述事項不會對公司生產經營造成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.